Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract

NCT ID: NCT05239715

Last Updated: 2023-09-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-10

Study Completion Date

2022-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To describe and compare the acquisition rate between different biometers in eyes with advanced cataracts

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To describe and compare the acquisition rate between different biometers in eyes with advanced cataracts

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Optical Biometer, Cataracts

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ocular biometry

Biometry using swept-source OCT Argos, swept-source OCT IOLMaster 700, swept-source OCT Anterion, PCI Pentacam AXL, OcuScan RxP and Itrace measurement

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* LOCS III cataract classification with a grade of ≥3 for nuclear, cortical or posterior subcapsular.
* DLI index, from the ITrace device, should be ≤ 5.

Exclusion Criteria

* Previous continuous contact lens wear
* Ocular trauma
* Intraocular lens surgery
* Poor fixation
* Corneal disease (i.e. keratoconus)
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role collaborator

OFTALVIST (Oftalmología Vistahermosa S.L)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pedro Tañá, Dr.

Role: PRINCIPAL_INVESTIGATOR

Oftalmología Vistahermosa SL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oftalmología Vistahermosa SL

Alicante, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Tana-Rivero P, Aguilar-Corcoles S, Tana-Sanz P, Tana-Sanz S, Montes-Mico R. Axial length acquisition success rates and agreement of four optical biometers and one ultrasound biometer in eyes with dense cataracts. Eye Vis (Lond). 2023 Sep 1;10(1):35. doi: 10.1186/s40662-023-00352-3.

Reference Type RESULT
PMID: 37653460 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BIO-CAT-DENSA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Laser Treatment of the Crystalline Lens
NCT01001117 UNKNOWN PHASE2/PHASE3